Addressing coronavirus disease 2019 (COVID-19) means addressing racism, according to 2 experts in the latest episode of Managed Care Cast.
Addressing coronavirus disease 2019 (COVID-19) means addressing racism, wrote Ingrid Katz, MD, assistant professor at Harvard Medical School, and Abraar Karan, MD, MPH, DTM&H, an internist at the Brigham and Women's Hospital and Harvard Medical School, in an opinion piece published in British Medical Journal.
In the latest Managed Care Cast, they speak with Patricia Salber, MD, MBA, of The Doctor Weighs In, about the article, why racism is an issue for doctors to address, and how well medicine is or is not doing with respect to addressing racism in admission to and graduation from medical school, teaching and studying the health impacts of racism in medical teaching, and encouraging more minority medical students to train as medical researchers.
Listen above or through one of these podcast services:
Read the original article by Katz and Karan.
Read more about racial and ethnic disparities in health care:
Addressing Cancer Disparities Requires Asking Questions and Putting Aside Assumptions
Does Intersection of Racial, Gender Biases Affect Heart Failure Treatment Decisions?
Dr Anthony Fauci on Health Disparities Affecting People of Color
Navigating Sport-Related Neurospine Injuries, Surgery, and Managed Care
February 25th 2025On this episode of Managed Care Cast, we speak with Arthur L. Jenkins III, MD, FACS, CEO of Jenkins NeuroSpine, to explore the intersection of advanced surgical care for sport-related neurospine injuries and managed care systems.
Listen
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
Neurologists Share Tips for Securing Patient Access to Gene Therapies
March 19th 2025Tenacious efforts at every level, from the individual clinician to the hospital to the state to Congress, will be needed to make sure patients can access life-saving gene therapies for neuromuscular diseases.
Read More